Perceptive Advisors’s Edesa Biotech EDSA Stock Holding History

Perceptive Advisors’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.58M	Hold	563,239	–	–	0.07%	94
2026 Q1	$2.95M	Buy	+563,239	New	+$1.69M	0.06%	83

Other funds holding EDSA

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Perceptive Advisors's EDSA Position: Q2 2026 in Review

Perceptive Advisors held its Edesa Biotech (EDSA) position steady in Q2 2026 at 563,239 shares worth $4.58M. The position accounts for 0.07% of the portfolio, ranked #94.

Perceptive Advisors first reported a position in EDSA in Q1 2026 and has held it in 2 quarters since. 33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

Perceptive Advisors held 563,239 shares of Edesa Biotech worth $4.58M as of Q2 2026.
Perceptive Advisors left its Edesa Biotech share count unchanged in Q2 2026.
Edesa Biotech made up 0.07% of Perceptive Advisors's portfolio in Q2 2026, its #94 holding.
Perceptive Advisors first reported a position in Edesa Biotech in Q1 2026 and has held it in 2 quarters since.
33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.